Zhukov B N, Kukol'nikova E L
Ter Arkh. 2004;76(12):48-50.
Assessment of clinical efficacy and tolerance of the drug Ginkor-Fort in patients with chronic venous insufficiency (CVI) in varicosity in compensation stage.
Thirty patients with compensated CVI free of trophic ulcers of the legs received Ginkor-Fort 1 capsule twice a day for one month. The efficacy of the drug was assessed by subjective appraisal of the patients, physical examination data and results of repeated measurements of the leg at the malleolus level.
A course of Ginkor Fort produced a considerable improvement in 27 (90%) patients. Improvement of the condition occurred in 3 (10%) patients. Side effects were absent, the treatment was well tolerated. All the patients completed a one-month Ginkor-Fort course.
Ginkor Fort is a highly effective and safe phlebotonic drug. Its high anti-inflammatory, anesthetic, lymphodraining and phlebotonic effects noticeably and rapidly raise life quality of patients with varicosity.
评估金纳多 forte 片对处于代偿期静脉曲张性慢性静脉功能不全(CVI)患者的临床疗效及耐受性。
30 例处于代偿期 CVI 且无腿部营养性溃疡的患者,每日两次,每次服用 1 粒金纳多 forte 片,疗程为 1 个月。通过患者主观评价、体格检查数据以及内踝水平腿部重复测量结果来评估药物疗效。
金纳多 forte 片一个疗程后,27 例(90%)患者病情显著改善。3 例(10%)患者病情有所改善。未出现副作用,治疗耐受性良好。所有患者均完成了为期 1 个月的金纳多 forte 片疗程。
金纳多 forte 片是一种高效且安全的促静脉回流药物。其强大的抗炎、止痛、促进淋巴回流及促静脉回流作用显著且迅速地提高了静脉曲张患者的生活质量。